Skip to main content
. 2021 Jan 11;128(7):1215–1224. doi: 10.1111/1471-0528.16618

Table 1.

Socio‐demographic characteristics of study participants

Variable n (% total)
Age at diagnosis Median age 66 years (IQR 56–73 years)
<50 years 61 (11.3%)
50–70 years 296 (54.9%)
>70 years 182 (33.8%)
Body mass index (BMI, kg/m2) Median BMI 32 kg/m2 (IQR 26–39 kg/m2)
Underweight 6 (1.1%)
Normal weight 83 (15.4%)
Overweight 128 (23.8%)
Obese 322 (59.7%)
Grade of endometrial cancer
1 243 (45.1%)
2 122 (22.6%)
3 174 (32.3%)
Stage of endometrial cancer
I 403 (74.9%)
II 56 (10.4%)
III 71 (13.0%)
IV 9 (1.7%)
Histology
Endometrioid 404 (75.0%)
Non‐endometrioid 135 (25.0%)
Bohkman’s category
Type 1 364 (67.5%)
Type 2 175 (32.5%)
Lymphovascular invasion (n = 536)
No 382 (71.3%)
Yes 154 (28.7%)
Depth of myometrial invasion
<50% 346 (64.2%)
≥50% 193 (35.8%)
Social deprivation group (n = 532)
Social group I (least deprived) 147 (27.6%)
Social group II (middle group) 186 (35.0%)
Social group III (most deprived) 199 (37.4%)
History of diabetes mellitus (n = 535)
Yes 108 (20.2%)
No 427 (79.8%)
Primary treatment
Surgery 473 (87.8%)
Hormonal (fertility‐sparing reasons) 23 (4.3%)
Hormonal (not fit for surgery) 40 (7.4%)
Radiotherapy 3 (0.6%)
Adjuvant treatment
Yes 240 (44.5%)
No 299 (55.5%)
Recurrence
Yes 78 (14.5%)
No 460 (85.5%)
Survival status at end of follow‐up
Alive 429 (79.6%)
Cancer‐specific mortality 76 (14.1%)
Non‐cancer related mortality 34 (6.3%)
Total 539 (100%)